
HotJul 22, 2026
With a comprehensive portfolio of GMP-grade cytokines—including E. coli-derived SCF, FLT3L, and TPO—alongside robust quality systems, global supply capabilities, and regulatory support, we are committed to enabling the next generation of HSPC-based cell and gene therapies from discovery to commercialization.
Read more
HotJul 13, 2026
Explore how GMP Activin A and KGF support scalable iPSC-derived islet cell manufacturing for diabetes therapy through efficient definitive endoderm induction, pancreatic progenitor differentiation, and clinical-scale production.
Read more
HotJun 16, 2026
Leveraging decades of protein expression expertise and extensive experimental datasets, the company has built a closed-loop AI protein engineering platform that combines computational prediction with laboratory validation. Powered by proprietary models such as DeepExp (0.95 accuracy for mammalian protein expression prediction) and ProDeSol (0.94 accuracy for protein solubility prediction), the platform enables the rapid development of recombinant proteins with enhanced stability, activity, and manufacturability.
Read moreReceive expert perspectives, research trends, and workflow guidance across emerging therapeutic fields.
お問い合わせ
グローバル:+1 800-810-0816(Toll Free)
メールアドレス
order.jp@acrobiosystems.com
アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8